Abstract: The invention relates to a bonding product comprising at least the polysaccharides T1 and T2, characterized in that a) the monosaccharides from which the polysaccharides T1 and T2 are constructed are partially or completely bonded to each other alpha-1,4-glycosidically and b) at least one of the polysaccharides T1 and/or T2 comprises at least one amino group and c) T1 and T2 are chemically bonded to each other covalently by at least one linker Z and d) T1 and/or T2 carries m groups -(L-A), wherein A is an active pharmaceutical ingredient and/or a fluorescence label, L is a second linker, by which T1 and/or T2 is covalently bonded to A, and m is an integer, which is 0 or at least 1.

Abstract: The invention relates to transport mediator-bonded colloids comprising pharmaceutical substances or fluorescence markers, to a method for the production thereof, and to a pharmaceutical preparation comprising said compounds.

Abstract: The invention relates to a bonding product comprising at least the polysaccharides T1 and T2, characterized in that a) the monosaccharides from which the polysaccharides T1 and T2 are constructed are partially or completely bonded to each other alpha-1,4-glycosidically and b) at least one of the polysaccharides T1 and/or T2 comprises at least one amino group and c) T1 and T2 are chemically bonded to each other covalently by at least one linker Z and d) T1 and/or T2 carries m groups -(L-A), wherein A is an active pharmaceutical ingredient and/or a fluorescence label, L is a second linker, by which T1 and/or T2 is covalently bonded to A, and m is an integer, which is 0 or at least 1.

Abstract: The invention relates to transport mediator-bonded colloids comprising pharmaceutical substances or fluorescence markers, to a method for the production thereof, and to a pharmaceutical preparation comprising said compounds.

Abstract: The invention relates to a bonding product suitable as a carrier for medicinal substances and to the compound derived therefrom that carries medicinal substances. The invention further relates to a process and device for preparing such bonding products and compounds. Further, the invention relates to a pharmaceutical composition containing such bonding products and compounds, and to the use thereof for preparing an infusible medicament for treating a disease.

Abstract: A device and method for movement and measurement of fluid volumes involves defining a fluid volume in a measuring chamber of a rotation vessel by at least first and second pistons movable within the measuring chamber, with the first and second pistons separating and indicating the volume of fluid moved into and out of the measuring chamber via flow-regulating valves. A holding means alternately holds the first and second pistons at fixed positions within the measuring chamber while the other piston rotates. A device and method of respiration involves a respirator including a plurality of flexible gas bags and a stiff gas tank with a first flexible gas bag positioned inside a second flexible gas bag and both gas bags being positioned inside the stiff tank. The respirator is connected to the device for the movement and measurement of fluid volumes via respirator valves.

Abstract: Procedure and device for determining cardiac output volume which involves applying an electrical potential to create a current flow through tissue of the patient's heart, placing a first measuring electrode on skin of the patient near the heart and inserting a second measuring electrode into the patient's body at a position on an opposite side of the heart from the first measuring electrode so that a straight-line heart-traversing projection extends through the heart between the first and the second measuring electrodes. In one embodiment the second measuring electrode is in a blood vessel and in another embodiment there are a plurality of second measuring electrodes with the best one being determined by Electrocardiogram equipment.

Abstract: Procedure of mechanical support of natural respiration and process of an artificial respiration with simultaneous registration of mechanical cardiac action via measurement of electric impedance variations within the region of the throat, breast and/or epigastrum, wherein a course of application of respiratory gas supply and respiratory gas restore carried out by the respiratory apparatus is controlled by progress of a measured impedance curve.